Julian Bion1. 1. Department of Intensive Care Medicine, University of Birmingham, Birmingham, UK. J.F.Bion@bham.ac.uk
Abstract
PURPOSE OF REVIEW: To examine the literature on competing interests for individuals and organizations involved in healthcare and to determine the nature and extent of the problem, and the most effective methods of management. RECENT FINDINGS: A Medline search from 1950 to August 2009 identified 6803 publications (605 in languages other than English) on the subject of conflict of interest or competing interests. Of these, 1073 were letters, 785 editorials, 434 reviews and 212 referred to competing interests in the context of clinical guidelines. Conflicts of interest (competing interests) and bias are ubiquitous. In medicine, they may have the potential to cause harm to patients or obstruct research and new treatments. Competing interests may arise from financial, academic or personal factors. Most interventions relate to managing competing financial interests derived from relationships with the pharmaceutical industry. SUMMARY: Transparency is a necessary, but not a sufficient component in managing bias. Organizations should develop integrated systems for declaring, monitoring and managing financial interests; insight into other forms of bias could be improved through educational programmes. Marketing masquerading as education should be prohibited for undergraduates and trainees, and by professional organizations. Universities and journals should separate their conflicted roles as regulators and beneficiaries in commercial relationships.
PURPOSE OF REVIEW: To examine the literature on competing interests for individuals and organizations involved in healthcare and to determine the nature and extent of the problem, and the most effective methods of management. RECENT FINDINGS: A Medline search from 1950 to August 2009 identified 6803 publications (605 in languages other than English) on the subject of conflict of interest or competing interests. Of these, 1073 were letters, 785 editorials, 434 reviews and 212 referred to competing interests in the context of clinical guidelines. Conflicts of interest (competing interests) and bias are ubiquitous. In medicine, they may have the potential to cause harm to patients or obstruct research and new treatments. Competing interests may arise from financial, academic or personal factors. Most interventions relate to managing competing financial interests derived from relationships with the pharmaceutical industry. SUMMARY: Transparency is a necessary, but not a sufficient component in managing bias. Organizations should develop integrated systems for declaring, monitoring and managing financial interests; insight into other forms of bias could be improved through educational programmes. Marketing masquerading as education should be prohibited for undergraduates and trainees, and by professional organizations. Universities and journals should separate their conflicted roles as regulators and beneficiaries in commercial relationships.
Authors: Camilla Hansen Nejstgaard; Lisa Bero; Asbjørn Hróbjartsson; Anders W Jørgensen; Karsten Juhl Jørgensen; Mary Le; Andreas Lundh Journal: Cochrane Database Syst Rev Date: 2020-12-08
Authors: Khaled Shawwa; Romy Kallas; Serge Koujanian; Arnav Agarwal; Ignacio Neumann; Paul Alexander; Kari A O Tikkinen; Gordon Guyatt; Elie A Akl Journal: PLoS One Date: 2016-03-31 Impact factor: 3.240
Authors: Shashi S Seshia; G Bryan Young; Michael Makhinson; Preston A Smith; Kent Stobart; Pat Croskerry Journal: J Eval Clin Pract Date: 2017-11-23 Impact factor: 2.431